Impact of energy-dense oral nutritional supplements on compliance with nutritional support after surgical treatment for gastric cancer: A multicenter phase II study.

Journal: Clinical Nutrition ESPEN
Published:
Abstract

Objective: Maintaining compliance with oral nutritional supplements (ONS) is a major problem in patients receiving nutritional support after surgical treatment for gastric cancer. The objective of this multicenter, single-arm phase II study was to test whether nutritional support with energy-dense ONS (1.6 kcal/mL) provides an average caloric intake of 200 kcal/day or more for a greater proportion of patients than that reported in previous studies.

Methods: Patients who underwent curative gastrectomy for gastric cancer were enrolled and received nutritional support with energy-dense ONS. ONS was initiated within three days after the start of the postoperative oral diet and continued until three months after surgery. The primary endpoint was the achievement rate (AR), which was defined as the proportion of patients who were able to achieve an average caloric intake of 200 kcal/day or more in nutritional support.

Results: Among 45 eligible patients who received nutritional support, 30 were able to achieve an average caloric intake of 200 kcal/day or more, and the AR was 66.7% (95% confidence interval, 53%-100%), which significantly differed from the threshold of 50% (P = 0.018). Grade 3 hypertriglyceridemia and grade 2 diarrhea were observed in one patient each. There were no significant differences in the percentage of body weight (BW) or the skeletal muscle index (SMI) between patients who consumed 200 kcal/day or more and those who consumed less than 200 kcal/day at three and 12 months after surgery.

Conclusions: Nutritional support with energy-dense ONS provides an average caloric intake of 200 kcal/day or more in a high proportion of patients after surgical treatment for gastric cancer without causing severe adverse events. However, the significant suppressive effect of energy-dense ONS on BW and SMI loss is not demonstrated (UMIN-CTR, https://www.umin.ac.jp/ctr/index.htm, study unique identifier: UMIN000045645).